318 related articles for article (PubMed ID: 34086150)
1. Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy.
Taku N; Wang L; Garden AS; Rosenthal DI; Gunn GB; Morrison WH; Fuller CD; Phan J; Reddy JP; Moreno AC; Spiotto MT; Chronowski G; Shah SJ; Mayo LL; Gross ND; Ferrarotto R; Zhu XR; Zhang X; Frank SJ
Curr Treat Options Oncol; 2021 Jun; 22(6):54. PubMed ID: 34086150
[TBL] [Abstract][Full Text] [Related]
2. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Youssef I; Yoon J; Mohamed N; Zakeri K; Press RH; Chen L; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Yu Y; Cohen MA; Dunn LA; Ho AL; Wong RJ; Michel LS; Boyle JO; Singh B; Kriplani A; Ganly I; Sherman EJ; Pfister DG; Fetten J; Lee NY
JAMA Netw Open; 2022 Nov; 5(11):e2241538. PubMed ID: 36367724
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma.
Sher DJ; Tishler RB; Pham NL; Punglia RS
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):875-882. PubMed ID: 29976499
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.
Blanchard P; Garden AS; Gunn GB; Rosenthal DI; Morrison WH; Hernandez M; Crutison J; Lee JJ; Ye R; Fuller CD; Mohamed AS; Hutcheson KA; Holliday EB; Thaker NG; Sturgis EM; Kies MS; Zhu XR; Mohan R; Frank SJ
Radiother Oncol; 2016 Jul; 120(1):48-55. PubMed ID: 27342249
[TBL] [Abstract][Full Text] [Related]
6. Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice.
Frank SJ; Cox JD; Gillin M; Mohan R; Garden AS; Rosenthal DI; Gunn GB; Weber RS; Kies MS; Lewin JS; Munsell MF; Palmer MB; Sahoo N; Zhang X; Liu W; Zhu XR
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):846-53. PubMed ID: 24867532
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinoma.
Gabani P; Lin AJ; Barnes J; Oppelt P; Adkins DR; Rich JT; Zevallos JP; Daly MD; Gay HA; Thorstad WL
Radiother Oncol; 2019 May; 134():81-88. PubMed ID: 31005228
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.
Zhang W; Zhang X; Yang P; Blanchard P; Garden AS; Gunn B; Fuller CD; Chambers M; Hutcheson KA; Ye R; Lai SY; Radwan MAS; Zhu XR; Frank SJ
Radiother Oncol; 2017 Jun; 123(3):401-405. PubMed ID: 28549794
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma.
Gunn GB; Blanchard P; Garden AS; Zhu XR; Fuller CD; Mohamed AS; Morrison WH; Phan J; Beadle BM; Skinner HD; Sturgis EM; Kies MS; Hutcheson KA; Rosenthal DI; Mohan R; Gillin MT; Frank SJ
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):360-367. PubMed ID: 27084653
[TBL] [Abstract][Full Text] [Related]
10. Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges.
Beddok A; Vela A; Calugaru V; Tessonnier T; Kubes J; Dutheil P; Gerard A; Vidal M; Goudjil F; Florescu C; Kammerer E; Benezery K; Herault J; Poortmans P; Bourhis J; Thariat J;
Radiother Oncol; 2020 Jun; 147():30-39. PubMed ID: 32224315
[TBL] [Abstract][Full Text] [Related]
11. Optimizing Radiotherapy in HPV-Associated Oropharyngeal Cancer Patients.
Langendijk JA; Steenbakkers RJ
Recent Results Cancer Res; 2017; 206():161-171. PubMed ID: 27699537
[TBL] [Abstract][Full Text] [Related]
12. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
Moreno AC; Frank SJ; Garden AS; Rosenthal DI; Fuller CD; Gunn GB; Reddy JP; Morrison WH; Williamson TD; Holliday EB; Phan J; Blanchard P
Oral Oncol; 2019 Jan; 88():66-74. PubMed ID: 30616799
[TBL] [Abstract][Full Text] [Related]
13. Practice patterns and outcomes following radiation dose de-escalation for oropharyngeal cancer.
White R; Abel S; Hasan S; Verma V; Greenberg L; Colonias A; Wegner RE
Laryngoscope; 2020 Apr; 130(4):E171-E176. PubMed ID: 31120601
[TBL] [Abstract][Full Text] [Related]
14. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
15. Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness.
Li G; Xia YF; Huang YX; Okat D; Qiu B; Doyen J; Bondiau PY; Benezery K; Gao J; Qian CN
BMC Cancer; 2021 Aug; 21(1):944. PubMed ID: 34419008
[TBL] [Abstract][Full Text] [Related]
16. De-escalation in HPV-associated oropharyngeal cancer: lessons learned from the past? A critical viewpoint and proposal for future research.
Petar S; Marko S; Ivica L
Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4599-4603. PubMed ID: 33599841
[TBL] [Abstract][Full Text] [Related]
17. Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002).
Yom SS; Torres-Saavedra P; Caudell JJ; Waldron JN; Gillison ML; Xia P; Truong MT; Kong C; Jordan R; Subramaniam RM; Yao M; Chung CH; Geiger JL; Chan JW; O'Sullivan B; Blakaj DM; Mell LK; Thorstad WL; Jones CU; Banerjee RN; Lominska C; Le QT
J Clin Oncol; 2021 Mar; 39(9):956-965. PubMed ID: 33507809
[TBL] [Abstract][Full Text] [Related]
18. Radiation Therapy Alone for Human Papillomavirus-Related Squamous Cell Carcinoma of the Oropharynx: A Single-Arm, Phase 2 Study.
Takemoto N; Seo Y; Nakahara S; Yoshioka Y; Teshima T; Fujii T; Isohashi F; Otani K; Yoshii T; Takenaka Y; Suzuki M; Fukusumi T; Hanamoto A; Yasui T; Michiba T; Yamamoto Y; Shimamoto S; Tanaka H; Tatsumi M; Ogawa K; Inohara H
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):403-411. PubMed ID: 33373656
[TBL] [Abstract][Full Text] [Related]
19. [Proton therapy for head and neck squamous cell carcinomas: From physics to clinic].
Beddok A; Vela A; Calugaru V; Tessonnier T; Kubes J; Dutheil P; Gérard A; Vidal M; Goudjil F; Florescu C; Kammerer E; Bénézery K; Hérault J; Bourhis J; Thariat J;
Cancer Radiother; 2019 Sep; 23(5):439-448. PubMed ID: 31358445
[TBL] [Abstract][Full Text] [Related]
20. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
